Bavarian Nordic A/S Stock Predictions

Frankfurt Stock Exchange

Open Broker Account

20.64€

+0 (+0%)

At Close: Dec 22, 2023

Currently predicting for Thu, 25 Apr 2024

BV3.F Predictions History

BE THE FIRST TO PREDICT

The excellent way of becoming a better trader

Easy to use
Enhance your skills
Predict as many as you like
Request predictions
Gather points

Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

About Bavarian Nordic A/S

Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... BV3.F Profile

Golden Star

Ticker	Date	Change	Price
LPLA	Apr 19	1.64%	$262.59
MLI	Apr 19	9.87%	$52.28
LNG	Apr 17	1.33%	$156.81
FCN	Apr 16	2.58%	$207.62
ELV	Apr 16	5.12%	$506.97
DXC	Apr 08	1.39%	$20.87
ITCI	Apr 05	8.14%	$68.44
AKR	Apr 05	6.84%	$16.53
NSIT	Apr 04	0.350%	$185.62
VSTS	Apr 04	0.638%	$18.82

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In